Abstract:Deep generative models are attracting much attention in the field of de novo molecule design. Compared to traditional methods, deep generative models can be trained in a fully data-driven way with little requirement for expert knowledge. Although many models have been developed to generate 1D and 2D molecular structures, 3D molecule generation is less explored, and the direct design of drug-like molecules inside target binding sites remains challenging. In this work, we introduce DeepLigBuilder, a novel deep learning-based method for de novo drug design that generates 3D molecular structures in the binding sites of target proteins. We first developed Ligand Neural Network (L-Net), a novel graph generative model for the end-to-end design of chemically and conformationally valid 3D molecules with high drug-likeness. Then, we combined L-Net with Monte Carlo tree search to perform structure-based de novo drug design tasks. In the case study of inhibitor design for the main protease of SARS-CoV-2, DeepLigBuilder suggested a list of drug-like compounds with novel chemical structures, high predicted affinity, and similar binding features to those of known inhibitors. The current version of L-Net was trained on drug-like compounds from ChEMBL, which could be easily extended to other molecular datasets with desired properties based on users' demands and applied in functional molecule generation. Merging deep generative models with atomic-level interaction evaluation, DeepLigBuilder provides a state-of-the-art model for structure-based de novo drug design and lead optimization.

Advances and Challenges in De Novo Drug Design Using Three-Dimensional Deep Generative Models

Advances in Deep Learning-Based 3D Molecular Generative Models

Deep Generative Models in De Novo Drug Molecule Generation

Molecular design in drug discovery: a comprehensive review of deep generative models

Graph-based generative models for de Novo drug design

Status and Prospects of Research on Deep Learning-based De Novo Generation of Drug Molecules

Advances and Challenges in Deep Generative Models for De Novo Molecule Generation

Deep learning approaches for <i>de novo</i> drug design: An overview

Comprehensive assessment of deep generative architectures for de novo drug design

Generative chemistry: drug discovery with deep learning generative models

Deep learning approaches for de novo drug design: An overview

Application progress of deep generative models in de novo drug design

Structure-based <i>de novo</i> drug design using 3D deep generative models

Deep Generative Design with 3D Pharmacophoric Constraints

Deep Learning Approaches for &lt;italic&gt;de Novo&lt;/italic&gt; Drug Design: an Overview

Recent Advances in Automated Structure-Based De Novo Drug Design

RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design

Deep Denerative Models for Drug Design and Response

Deep Generative Molecular Design Reshapes Drug Discovery

Learning to design drug-like molecules in three-dimensional space using deep generative models

Advances in De Novo Drug Design: From Conventional to Machine Learning Methods